Fed. Circ. Revives Competition Claims In Latisse Suit
The Federal Circuit revived Allergan Inc.'s California unfair competition claims Tuesday in a suit accusing several companies of infringing patents for eyelash treatment Latisse, ruling that alleging an injury in fact...To view the full article, register now.
Already a subscriber? Click here to view full article